Jamison Eaton & Wood’s GSK GSK Stock Holding History

Jamison Eaton & Wood’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,618	Closed	-$101K	–	154
2013 Q3	$101K	Buy	+1,618	New	+$104K	0.03%	134

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jamison Eaton & Wood's GSK Position: Q4 2013 in Review

Jamison Eaton & Wood sold out of GSK (GSK) in Q4 2013, closing a stake of 1,618 shares — an estimated $101K sold.

Jamison Eaton & Wood first reported a position in GSK in Q3 2013 and held it in 1 quarter. The position peaked at $101K in Q3 2013. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

Jamison Eaton & Wood reported no remaining GSK position as of Q4 2013 after selling out during the quarter.
Jamison Eaton & Wood sold 1,618 GSK shares in Q4 2013, an estimated $101K.
Jamison Eaton & Wood first reported a position in GSK in Q3 2013 and held it in 1 quarter.
Jamison Eaton & Wood's GSK position peaked at $101K in Q3 2013.
681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on Jamison Eaton & Wood's 13F filing for Q4 2013, filed 11 Feb 2014.